Data News > Overweight Recommendation Issued On STZ By Barclays

Overweight Recommendation Issued On STZ By Barclays

By KlickAnalytics Data Insights  |   May 28, 2024 10:30PM ET

  • Barclays analyst issues OVERWEIGHT recommendation for STZ on May 28, 2024 08:49PM ET.
  • The previous analyst recommendation was Overweight.
  • STZ was trading at $245.49 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 15 - Buy, 2 - Hold recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations
    Report DateAnalyst CompanyActionPrevious GradeNew GradePrice when posted
    2024-05-28 Barclays Hold Overweight Overweight 245.49
    2024-05-28 RBC Capital Hold Outperform Outperform 248.51
    2024-05-14 Jefferies Hold Buy Buy 258.77
    2024-04-19 Cowen & Co. Hold Buy Buy 261.52
    2024-04-15 Argus Research Upgrade Reduce 258.99
    2024-04-12 HSBC Hold Buy Buy 268.34
    2024-04-12 UBS Hold Buy Buy 268.34
    2024-04-12 Jefferies Hold Buy Buy 268.34
    2024-04-12 BMO Capital Hold Outperform Outperform 268.34
    2024-04-12 Goldman Sachs Hold Conviction Buy Conviction Buy 268.34

    Historical Price Performance



    For more information:
  • Analyst Recommendations
  • Historical Price Targets
  • Earning Price Impact Analysis
  • Seasonality Analysis
  • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.